---
title: Global Reference Ranges - Singapore
nct_id: NCT07166471
overall_status: NOT_YET_RECRUITING
sponsor: Perspectum
study_type: OBSERVATIONAL
primary_condition: Healthy Participants
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT07166471.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07166471"
ct_last_update_post_date: 2025-12-05
last_seen_at: "2026-05-12T07:21:34.013Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Global Reference Ranges - Singapore

**NCT ID:** [NCT07166471](https://clinicaltrials.gov/study/NCT07166471)

## Key Facts

- **Status:** NOT_YET_RECRUITING
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 50
- **Lead Sponsor:** Perspectum
- **Collaborators:** National Heart Centre Singapore
- **Conditions:** Healthy Participants
- **Start Date:** 2025-12-31
- **Completion Date:** 2027-09
- **CT.gov Last Update:** 2025-12-05

## Brief Summary

We aim to undertake the Global Reference Range Study (GRR) to establish a set of healthy adult reference values for measures of fibroinflammation, fat and size/volumes for the liver, and other abdominal and thoracic organs to assess, compare, and if necessary, propose ethnicity specific reference ranges for these measurements.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL

```
Inclusion Criteria:

* Male or female at least 18 years of age
* Self-reported healthy
* Willing and able to give informed consent for participation in the study
* Willing and able to undergo an MRI

Exclusion Criteria:

* History of cardiovascular disease as follows:

  * Myocardial infarction
  * Heart failure
  * Cardiomyopathy
  * Stroke
  * Hospital admission/discharge for unstable angina
  * Heart surgery
  * Unstable angina
  * Transient ischemic attack
* Presence of CVD risk factors such as hypertension, hyperlipidaemia, Type 2 diabetes, BMI \> 30 kg/m2, smoker (current/ex-smoker)
* History of non-cardiac diseases related to the lungs, liver, kidneys, pancreas or spleen judged by the study investigator as therefore unsuitable to participate in the study
* The participant may not enter the study if they have any contraindication to magnetic resonance imaging (standard MRI exclusion criteria including pregnancy, extensive tattoos, pacemaker, shrapnel injury, severe claustrophobia)
* Any other cause, including a significant disease or disorder which, in the opinion of the investigator, may either put the participant at risk because of participation in the study, or may influence the participant's ability to participate in the study
```

## Primary Outcomes

- **To determine the reference values for liver fibroinflammation in healthy adults from different ethnic groups.** _(time frame: 24 months)_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT07166471.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT07166471*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*